Works matching IS 0171-5216 AND VI 149 AND IP 2 AND DT 2023

Results: 32

Establishing a metastasis-related diagnosis and prognosis model for lung adenocarcinoma through CRISPR library and TCGA database.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 885, doi. 10.1007/s00432-022-04495-z

By:

Shao, Fanggui;
Ling, Liqun;
Li, Changhong;
Huang, Xiaolu;
Ye, Yincai;
Zhang, Meijuan;
Huang, Kate;
Pan, Jingye;
Chen, Jie;
Wang, Yumin

Publication type:

Article

HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 737, doi. 10.1007/s00432-022-04493-1

By:

Jiang, Ning;
Yu, Yue;
Wu, Dawei;
Wang, Shuhang;
Fang, Yuan;
Miao, Huilei;
Ma, Peiwen;
Huang, Huiyao;
Zhang, Min;
Zhang, Yu;
Tang, Yu;
Li, Ning

Publication type:

Article

Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 669, doi. 10.1007/s00432-022-04416-0

By:

Torlot, Lucien;
Jarzab, Anna;
Albert, Johanna;
Pók-Udvari, Ágnes;
Stahler, Arndt;
Holch, Julian Walter;
Gerlinger, Marco;
Heinemann, Volker;
Klauschen, Frederick;
Kirchner, Thomas;
Kumbrink, Jörg;
Küster, Bernhard;
Jung, Andreas

Publication type:

Article

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 913, doi. 10.1007/s00432-022-04407-1

By:

Arndt, Volker;
Doege, Daniela;
Fröhling, Stefan;
Albers, Peter;
Algül, Hana;
Bargou, Ralf;
Bokemeyer, Carsten;
Bornhäuser, Martin;
Brandts, Christian H.;
Brossart, Peter;
Brucker, Sara Yvonne;
Brümmendorf, Tim H.;
Döhner, Hartmut;
Gattermann, Norbert;
Hallek, Michael;
Heinemann, Volker;
Keilholz, Ulrich;
Kindler, Thomas;
von Levetzow, Cornelia;
Lordick, Florian

Publication type:

Article

Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 683, doi. 10.1007/s00432-022-04385-4

By:

Shen, Chongxing;
Yue, Xiaofeng;
Dai, Linyong;
Wang, Jianwu;
Li, Jinjin;
Fang, Qiang;
Zhi, Yi;
Shi, Chunmeng;
Li, Weibing

Publication type:

Article

Clinical features and response to systemic therapy in NRAS-mutant Chinese melanoma patients.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 701, doi. 10.1007/s00432-022-04377-4

By:

Wang, Jiuhong;
Jiang, Hang;
Huang, Fuxue;
Li, Dandan;
Wen, Xizhi;
Ding, Qiuyue;
Ding, Ya;
Zhang, Xiaoshi;
Li, Jingjing

Publication type:

Article

Tumor characteristics, therapy, and prognosis in young breast cancer patients ≤ 35 years.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 709, doi. 10.1007/s00432-022-04374-7

By:

Eckardt, Naaja-Kristin;
Ignatov, Atanas;
Meinecke, Anne-Marie;
Burger, Elke;
Costa, Serban-Dan;
Eggemann, Holm

Publication type:

Article

Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry data.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 721, doi. 10.1007/s00432-022-04369-4

By:

Engel, Jutta;
Eckel, Renate;
Halfter, Kathrin;
Schubert-Fritschle, Gabriele;
Hölzel, Dieter

Publication type:

Article

TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 653, doi. 10.1007/s00432-022-04363-w

By:

Chen, Jianping;
Wang, Dandan;
Chen, Hongqiang;
Gu, Jin;
Jiang, Xiao;
Han, Fei;
Cao, Jia;
Liu, Wenbin;
Liu, Jinyi

Publication type:

Article

NOD2 inhibits the proliferation of esophageal adenocarcinoma cells through autophagy.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 639, doi. 10.1007/s00432-022-04354-x

By:

Li, Xiaozhi;
Liu, Suo;
Jin, Longyu;
Ma, Yuchao;
Liu, Tao

Publication type:

Article

Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years.

Published in:

2023

By:

Kürzel, Sabine;
Blaudszun, André‑René;
Stahl, Lilly;
Herbst, Regina;
Kroschinsky, Frank;
Birkmann, Josef;
Hänel, Annette;
Schaefer-Eckart, Kerstin;
Ehninger, Gerhard;
Fiedler, Friedrich;
Bornhäuser, Martin;
Fricke, Stephan;
Hänel, Mathias

Publication type:

Correction Notice

Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 877, doi. 10.1007/s00432-022-04299-1

By:

Fan, Christopher;
Kim, Ahyoung;
Li, Sean;
Naidoo, Jarushka;
Cappelli, Laura C.;
Brahmer, Julie R.;
Anders, Robert A.;
Kim, Amy K.

Publication type:

Article

Case report: identification of EGFR R776H and FANCE R381H germline mutations in a patient with multiple pulmonary nodules.

Published in:

2023

By:

Wu, Zhenzhen;
Wang, Yanli;
Jin, Linling;
Wei, Juan;
Han, Li;
Su, Junyan;
Cao, Shuliang;
Liu, Siyao;
Duan, Xiaohong;
Zhao, Xin

Publication type:

Case Study

Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 623, doi. 10.1007/s00432-022-04285-7

By:

Li, Yi-Fei;
Hou, Qiong-Qiong;
Zhao, Shuang;
Chen, Xiaoyan;
Tang, Min;
Li, Lin

Publication type:

Article

The therapeutic effect of an autologous and allogenic mixed glioma cell lysate vaccine in a rat model.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 609, doi. 10.1007/s00432-022-04281-x

By:

He, Haiping;
Cen, Yulin;
Wang, Ping;
Zeng, Xu;
Zeng, Shan;
Li, Xinlong;
Lu, Xiaofei;
Zhong, Chuanhong;
Ming, Yang;
Chen, Ligang;
Peng, Lilei

Publication type:

Article

Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 553, doi. 10.1007/s00432-022-04280-y

By:

Hu, Po;
Wan, Peng;
Xu, Anna;
Yan, Binghui;
Liu, Chunmei;
Xu, Qixuan;
Wei, Zhenhuan;
Xu, Jingyi;
Liu, Siqi;
Yang, Guangming;
Pan, Yang

Publication type:

Article

Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 567, doi. 10.1007/s00432-022-04274-w

By:

Pereira, Érica Romão;
Pinheiro, Laís Capelasso Lucas;
Francelino, Amanda Letícia;
Miqueloto, Carlos Alberto;
Guembarovski, Alda Fiorina Maria Losi;
de Oliveira, Karen Brajão;
Fuganti, Paulo Emílio;
de Syllos Cólus, Ilce Mara;
Guembarovski, Roberta Losi

Publication type:

Article

Enhancing the immune effect of oHSV-1 therapy through TLR3 signaling in uveal melanoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 901, doi. 10.1007/s00432-022-04272-y

By:

Liu, Sisi;
Li, Mingxin;
Sun, Fengqiao;
Zhang, Junwen;
Liu, Fusheng

Publication type:

Article

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 579, doi. 10.1007/s00432-022-04230-8

By:

Sun, Qi;
Li, Qi;
Gao, Fuping;
Wu, Hongyan;
Fu, Yao;
Yang, Jun;
Fan, Xiangshan;
Cui, Xiaobin;
Pu, Xiaohong

Publication type:

Article

Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 593, doi. 10.1007/s00432-022-04162-3

By:

Tan, Wei;
Liu, Shiyi;
Deng, Zhimin;
Dai, Fangfang;
Yuan, Mengqin;
Hu, Wei;
Li, Bingshu;
Cheng, Yanxiang

Publication type:

Article

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 865, doi. 10.1007/s00432-022-03984-5

By:

Gursoy, Pınar;
Tatli, Ali Murat;
Erdem, Dilek;
Goker, Erdem;
Celik, Emir;
Demirci, Nebi Serkan;
Sakin, Abdullah;
Atci, Muhammed Mustafa;
Bayram, Ertuğrul;
Telli, Tuğba Akın;
Bilgin, Burak;
Bilici, Ahmet;
Akangunduz, Baran;
Balli, Sevinç;
Demirkazik, Ahmet;
Selçukbiricik, Fatih;
Menekse, Serkan;
Cavdar, Eyyüp;
Ozturk, Akın;
Bekmez, Esma Türkmen

Publication type:

Article

Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 803, doi. 10.1007/s00432-022-03954-x

By:

Röhrmoser, Katharina;
Ignatov, Atanas;
Gerken, Michael;
Ortmann, Olaf;
Klinkhammer-Schalke, Monika;
Papathemelis, Thomas

Publication type:

Article

Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 841, doi. 10.1007/s00432-022-03950-1

By:

Poon, Darren M. C.;
Yang, Bin;
Geng, Hui;
Wong, Oi Lei;
Chiu, Sin Ting;
Cheung, Kin Yin;
Yu, Siu Ki;
Chiu, George;
Yuan, Jing

Publication type:

Article

TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 833, doi. 10.1007/s00432-022-03939-w

By:

Eckardt, Julia;
Schroeder, Christopher;
Martus, Peter;
Armeanu-Ebinger, Sorin;
Kelemen, Olga;
Gschwind, Axel;
Bonzheim, Irina;
Eigentler, Thomas;
Amaral, Teresa;
Ossowski, Stephan;
Rieß, Olaf;
Flatz, Lukas;
Garbe, Claus;
Forschner, Andrea

Publication type:

Article

Burnout among German oncologists: a cross-sectional study in cooperation with the Arbeitsgemeinschaft Internistische Onkologie Quality of Life Working Group.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 765, doi. 10.1007/s00432-022-03937-y

By:

Helaß, Madeleine;
Haag, Georg Martin;
Bankstahl, Ulli Simone;
Gencer, Deniz;
Maatouk, Imad

Publication type:

Article

The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 851, doi. 10.1007/s00432-022-03934-1

By:

Anic, Katharina;
Altehoefer, Christin;
Krajnak, Slavomir;
Schmidt, Mona Wanda;
Schwab, Roxana;
Linz, Valerie Catherine;
Schmidt, Marcus;
Westphalen, Christiane;
Hartmann, Erik Kristoffer;
Hasenburg, Annette;
Battista, Marco Johannes

Publication type:

Article

Treatment outcomes and prognostic factors in 47 patients with primary anorectal malignant melanoma in the immune therapy era.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 749, doi. 10.1007/s00432-022-03933-2

By:

Ogata, Dai;
Tsutsui, Keita;
Namikawa, Kenjiro;
Moritani, Konosuke;
Nakama, Kenta;
Jinnai, Shunichi;
Takahashi, Akira;
Tsukamoto, Shunsuke;
Kanemitsu, Yukihide;
Yamazaki, Naoya

Publication type:

Article

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 791, doi. 10.1007/s00432-022-03915-4

By:

Schönberger, Stefan;
Mohseni, Mahsa Mir;
Ellinger, Jörg;
Tran, Giao Vu Quynh;
Becker, Martina;
Claviez, Alexander;
Classen, Carl-Friedrich;
Hermes, Barbara;
Driever, Pablo Hernáiz;
Jorch, Norbert;
Lauten, Melchior;
Mehlitz, Marcus;
Schäfer, Niklas;
Scheer-Preiss, Johanna;
Schneider, Dominik T.;
Troeger, Anja;
Calaminus, Gabriele;
Dilloo, Dagmar

Publication type:

Article

Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 757, doi. 10.1007/s00432-021-03903-0

By:

Lin, Xinqing;
Deng, Haiyi;
Li, Suyang;
Xie, Xiaohong;
Chen, Chao;
Cai, Longqiu;
Yang, Yilin;
Qiu, Guihuan;
Xie, Zhanhong;
Qin, Yinyin;
Liu, Ming;
Zhou, Chengzhi

Publication type:

Article

Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 779, doi. 10.1007/s00432-021-03898-8

By:

Cao, Yanshuo;
Lu, Ming;
Sun, Yu;
Gong, Jifang;
Li, Jie;
Lu, Zhihao;
Li, Jian;
Zhang, Xiaotian;
Li, Yan;
Peng, Zhi;
Zhou, Jun;
Wang, Xicheng;
Shen, Lin

Publication type:

Article

Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 819, doi. 10.1007/s00432-021-03896-w

By:

Sun, Chao;
Liu, Yunpeng;
Zhang, Peng;
Wang, Xu;
Xu, Yinghui;
Lin, Xingyu;
Ma, Xiaobo;
Guo, Ye;
Qiu, Shi;
Shao, Guoguang;
Yang, Zhiguang;
Ma, Kewei

Publication type:

Article

Anti-CD20–atezolizumab–polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 811, doi. 10.1007/s00432-021-03847-5

By:

Topp, Max S.;
Eradat, Herbert;
Florschütz, Axel;
Hochhaus, Andreas;
Wrobel, Tomasz;
Walewski, Jan;
Knopinska-Posluszny, Wanda;
Kanate, Abraham S.;
Lech-Maranda, Ewa;
Brunnberg, Uta;
Chitra, Surya;
Nielsen, Tina G.;
Sellam, Gila;
Shivhare, Mahesh;
Lossos, Izidore S.

Publication type:

Article